The Current and Future Role of CD20 x CD3 Bispecific Antibodies in the Management of Non-Hodgkin Lymphoma - a podcast by Research To Practice

Dr Martin Hutchings from Rigshospitalet, Copenhagen University Hospital in Copenhagen, Denmark, and Dr Loretta Nastoupil from The University of Texas MD Anderson Cancer Center in Houston, Texas, discuss the current and future role of CD20 x CD3 bispecific antibodies in the management of non-Hodgkin lymphoma moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here (https://researchtopractice.com/InsidetheIssue2023/NHL)

Further episodes of Oncology Today with Dr Neil Love

Further podcasts by Research To Practice

Website of Research To Practice